Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges;Einführung eines organisierten Darmkrebs-Screenings in Deutschland: Chancen und Herausforderungen

Gesundheitswesen

Volumn 77, Issue 11, 2015, Pages 869-874

  Haug, U ^a   Rosch T ^b   Hoffmeister, M ^a   Katalinic, A ^c   Brenner, H ^a   Becker, N ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

colorectal cancer; early detection; invitation system; organised screening; quality assurance

Indexed keywords

COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; GERMANY; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH PROMOTION; HUMAN; NEEDS ASSESSMENT; NONBIOLOGICAL MODEL; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PRIMARY PREVENTION; PROCEDURES; REMINDER SYSTEM; STANDARDS;

COLORECTAL NEOPLASMS; DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; GERMANY; GOVERNMENT PROGRAMS; HEALTH PROMOTION; HUMANS; MODELS, ORGANIZATIONAL; NEEDS ASSESSMENT; ORGANIZATIONAL OBJECTIVES; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; REMINDER SYSTEMS;

EID: 84948078710     PISSN: 09413790     EISSN: 14394421     Source Type: Journal    
DOI: 10.1055/s-0034-1377027     Document Type: Article

References (41)

1. Krebs in Deutschland 2007/2008 Robert Koch-Institut Hrsg und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. 8. Ausgabe Hrsg Berlin: 2012
2. Hewitson P., Glasziou P., Irwig L. et al. Screening for colorectal cancer using the fecal occult blood test, Hemoccult. Cochrane Database Syst Rev: 2007; CD001216
3. Brenner H., Chang-Claude J., Jansen L. et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology: 2014; 146 709 717
4. Nishihara R., Wu K., Lochhead P. et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med: 2013; 369 1095 1105
5. Quinn M., Babb P., Jones J. et al. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ: 1999; 318 904 908
6. Nygard J. F., Skare G. B., Thoresen S. O. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen: 2002; 9 86 91
7. Ronco G., Pilutti S., Patriarca S. et al. Impact of the introduction of organized screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98. Br J Cancer: 2005; 93 376 378
8. Segnan N., Patnick J., von Karsa L. (eds.). European guidelines for quality assurance in colorectal cancer screening and diagnosis -. first edition Luxembourg European Commission, publications office of the European Union: 2010
9. Bundesgesetzblatt Teil I 2013, Nr. 16: 617
10. Segnan N., Senore C., Andreoni B. et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst: 2005; 97 347 357
11. Multicentre Australian Colorectal-neoplasia screening (MACS) Group A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust: 2006; 184 546 550
12. Inadomi J. M., Vijan S., Janz N. K. et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med: 2012; 172 575 582
13. Hol L., Kuipers E. J., van Ballegooijen M. et al. Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme. Int J Cancer: 2012; 130 2096 2102
14. van Dam L., Kuipers E. J., Steyerberg E. W. et al. The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies? Lancet Oncol: 2013; 14 e38 e46
15. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Kolorektales Karzinom, Langversion 1.0, AWMF Registrierungsnummer: 021-007OL http://leitlinienprogramm-onkologie.de/Leitlinien.7.0.html
16. van Rossum L. G., van Rijn A. F., Laheij R. J. et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology: 2008; 135 82 90
17. Haug U., Hundt S., Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: Evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol: 2010; 105 682 690
18. Brenner H., Tao S. Superior diagnostic performance of fecal immunochemical tests for hemoglobin in a head-to-head comparison with guaiac based fecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer: 2013; 49 3049 3054
19. Hoffman R. M., Steel S., Yee E. F. et al. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med: 2010; 50 297 299
20. Hundt S., Haug U., Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med: 2009; 150 162 169
21. Brenner H., Haug U., Hundt S. Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer: 2010; 127 1643 1649
22. van Roon A. H., Goede S. L., van Ballegooijen M. et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut: 2013; 62 409 415
23. Crispin A., Birkner B., Munte A. et al. Process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies. Endoscopy: 2009; 41 1018 1025
24. Day L. W., Kwon A., Inadomi J. M. et al. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc: 2011; 74 885 896
25. Sieverding M., Matterne U., Ciccarello L. et al. Colonoscopy use in a country with a long-standing colorectal cancer screening programme: evidence from a large German survey. Z Gastroenterol: 2010; 48 1351 1357
26. Robert Koch-Institut Hrsg Daten und Fakten: Ergebnisse der Studie «Gesundheit in Deutschland aktuell 2010». Beiträge zur Gesundheitsberichterstattung des Bundes. Berlin RKI: 2012
27. Hoffmeister M., Chang-Claude J., Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol: 2007; 166 130 136
28. Sabatino S. A., Lawrence B., Elder R. et al. Community Preventive Services Task Force Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med: 2012; 43 97 118
29. Denberg T. D., Melhado T. V., Coombes J. M. et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med: 2005; 20 989 995
30. Church T. R., Yeazel M. W., Jones R. M. et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst: 2004; 96 770 780
31. Brenner H., Chang-Claude J., Jansen L. et al. Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection: a population-based case-control study. Ann Intern Med: 2012; 157 225 232
32. Brenner H., Chang-Claude J., Seiler C. M. et al. Interval cancers after negative colonoscopy: population-based case-control study. Gut: 2012; 61 1576 1582
33. Lee T. J., Rutter M. D., Blanks R. G. et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut: 2012; 61 1050 1057
34. Etzioni D. A., Yano E. M., Rubenstein L. V. et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum: 2006; 49 1002 1010
35. Yabroff K. R., Washington K. S., Leader A. et al. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening result. Med Care Res Rev: 2003; 60 294 331
36. Heitman S. J., Ronksley P. E., Hilsden R. J. et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol: 2009; 7 1272 1278
37. Radaelli F., Paggi S., Bortoli A. et al. Italian Association of Hospital Gastroenterologists (AIGO) Overutilization of post-polypectomy surveillance colonoscopy in clinical practice: a prospective, multicentre study. Dig Liver Dis: 2012; 44 748 753
38. Schoen R. E., Pinsky P. F., Weissfeld J. L. et al. Utilization of surveillance colonoscopy in community practice. Gastroenterology: 2010; 138 73 81
39. Stock C., Hoffmeister M., Birkner B. et al. Inter-physician variation in follow-up colonoscopies after screening colonoscopy. PLoS One: 2013; 8 e69312
40. th 2013
41. Adler A., Lieberman D., Aminalai A. et al. Data quality of the German Screening Colonoscopy Registry. Endoscopy: 2013; 45 813 818